Using sorafenib for recurrent hepatocellular Carcinoma after liver transplantation-interactions between calcineurin inhibitor: Two case reports

Transplantation Proceedings

Volumn 43, Issue 7, 2011, Pages 2800-2805

  Takahara, T ^a   Nitta, H ^a   Hasegawa, Y ^a   Itou, N ^a   Takahashi, M ^a   Wakabayashi, G ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CALCINEURIN INHIBITOR; CISPLATIN; CYCLOSPORIN; FLUOROURACIL; GEMCITABINE; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; OXALIPLATIN; SORAFENIB; TACROLIMUS;

ADULT; ADVANCED CANCER; ANOREXIA; AREA UNDER THE CURVE; ARTICLE; BONE METASTASIS; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CASE REPORT; CHEMOEMBOLIZATION; COMPUTER ASSISTED TOMOGRAPHY; DIARRHEA; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG USE; DRUG WITHDRAWAL; GASTROINTESTINAL SYMPTOM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; ILIAC METASTASIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER TRANSPLANTATION; LIVING DONOR; LUNG METASTASIS; LUNG SURGERY; MALE; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIMAL DRUG DOSE; PRIORITY JOURNAL; RECURRENT CANCER; SKIN DISEASE;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CALCINEURIN; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PYRIDINES; RECURRENCE;

EID: 80052733261     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.06.063     Document Type: Article

References (27)

1. D.M. Parkin, F. Bray, and J. Ferlay Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
2. F. Kamangar, G.M. Dores, and W.F. Anderson Patterns of cancer incidence, mortality, and prevalence across 5 continents: defining priorities to reduce cancer disparities in different geographic regions of the world J Clin Oncol 24 2006 2137
3. T. Umemura, T. Ichijo, and K. Yoshizawa Epidemiology of hepatocellular carcinoma in Japan J Gastroenterol 44 suppl 19 2009 102
4. V. Mazzaferro, E. Regalia, and R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693
5. H. Bismuth, P.E. Majno, and R. Adam Liver transplantation for hepatocellular carcinoma Semin Liver Dis 19 1999 311
6. S. Kaihara, T. Kiuchi, and M. Ueda Living-donor liver transplantation for hepatocellular carcinoma Transplantation 75 2003 S37
7. H.Y. Yoo, C.H. Patt, and J.F. Geschwind The outcome of liver transplantation in patients with hepatocellular carcinoma in the United States between 1988 and 2001: 5-year survival has improved significantly with time J Clin Oncol 21 2003 4329
8. V.H. De Villa, C.M. Lo, and C.L. Chen Ethics and rationale of living-donor liver transplantation in Asia Transplantation 75 2003 S2
9. S. Todo, and H. Furukawa Japanese Study on Organ Transplantation: Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan Ann Surg 240 2004 451
10. H. Furukawa, T. Shimamura, and T. Suzuki Liver transplantation for hepatocellular carcinoma: the Japanese experience J Hepatobiliary Pancreat Sci 17 2010 533
11. Y. Takada, and S. Uemoto Liver transplantation for hepatocellular carcinoma: the Kyoto experience J Hepatobiliary Pancreat Sci 17 2010 527
12. Y. Sugawara, S. Tamura, and M. Makuuchi Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series Dig Dis 25 2007 310
13. A. Taketomi, K. Sanefuji, and Y. Soejima Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation Transplantation 87 2009 531
14. H.J. Schlitt, M. Neipp, and A. Weimann Recurrence patterns of hepatocellular and fibrolamellar carcinoma after liver transplantation J Clin Oncol 17 1999 324
15. S. Roayaie, J.D. Schwartz, and M.W. Sung Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis Liver Transpl 10 2004 534
16. J.M. Llovet, S. Ricci, and V. Mazzaferro Sorafenib in advanced hepatocellular carcinoma N Engl J Med 359 2008 378
17. H. Minami, K. Kawada, and H. Ebi Phase I and pharmacokinetic study of sorafenib, an oral multikinase inhibitor, in Japanese patients with advanced refractory solid tumors Cancer Sci 99 2008 1492
18. M. Sakon, H. Nagano, and K. Dono Combined intraarterial 5-fluorouracil and subcutaneous interferon-α therapy for advanced hepatocellular carcinoma with tumor thrombi in the major portal branches Cancer 94 2002 435
19. H. Nagano, A. Miyamoto, and H. Wada Interferon-a and 5-fluorouracil combination therapy after palliative hepatic resection in patients with advanced hepatocellular carcinoma, portal venous tumor thrombus in the major trunk, and multiple nodules Cancer 110 2007 2493
20. M. Kudo, H. Chung, and S. Haji Validation of a new prognostic staging system for hepatocellular carcinoma: the JIS score compared with the CLIP score Hepatology 40 2004 1396
21. M. Kudo, H. Chung, and Y. Osaki Prognostic staging system for hepatocellular carcinoma (CLIP score): its value and limitations, and a proposal for a new staging system, the Japan Integrated Staging Score (JIS score) J Gastroenterol 38 2003 207
22. M. Nakamura, H. Nagano, and S. Marubashi Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-alpha for advanced hepatocellular carcinoma with extrahepatic metastasis Cancer 112 2008 1765
23. Y. Fukuda, N. Fujio, and H. Takatori Complete response to treatment with low-dose FP therapy in a patient with stage IVB primary hepatocellular carcinoma with multiple lung and bone metastases Gan To Kagaku Ryoho 31 2004 1105
24. A. Tsuchiya, M. Imai, and H. Kamimura Successful treatment of multiple lung metastases of hepatocellular carcinoma by combined chemotherapy with docetaxel, cisplatin and tegafur/uracil World J Gastroenterol 15 2009 1779
25. S. Louafi, V. Boige, and M. Ducreux Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study Cancer 109 2007 1384
26. S. Saab, M. McTigue, and R.S. Finn Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy Exp Clin Transplant 8 2010 307
27. R. Kim, G. El-Gazzaz, and A. Tan Safety and feasibility of using sorafenib in recurrent hepatocellular carcinoma after orthotopic liver transplantation Oncology 79 2010 62